Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study

被引：0
|
作者：
Emma Houchen
Emil Loefroth
Raymond Schlienger
Clare Proudfoot
Stefano Corda
Sibasish Saha
Sarvesh K. Satwase
Rachel Studer
机构：
[1] Novartis Ireland Ltd.,
[2] Novartis Sweden AB,undefined
[3] Novartis Pharma AG,undefined
[4] Novartis Healthcare Pvt. Ltd,undefined
[5] Medical and Knowledge Solutions,undefined
[6] Novartis Global Service Center,undefined
来源：
Cardiology and Therapy | 2022年 / 11卷
关键词：
Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Angiotensin receptor neprilysin inhibitor; Heart failure; Sacubitril/valsartan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：113 / 127
页数：14
相关论文
共 50 条
  • [21] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [22] Are angiotensin-converting enzyme inhibitors or angiotensin 2 receptor antagonists effective in heart failure with preserved ejection fraction?
    Rain, Carmen
    Rada, Gabriel
    MEDWAVE, 2015, 15 (02): : e6101
  • [23] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for heart failure patients with different left ventricular ejection fraction categories: from the KCHF Registry
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Kato, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 374 - 374
  • [24] Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
    Sunaga, Akihiro
    Hikoso, Shungo
    Tamaki, Shunsuke
    Seo, Masahiro
    Yano, Masamichi
    Hayashi, Takaharu
    Nakagawa, Akito
    Nakagawa, Yusuke
    Kurakami, Hiroyuki
    Yamada, Tomomi
    Kitamura, Tetsuhisa
    Sato, Taiki
    Oeun, Bolrathanak
    Kida, Hirota
    Sotomi, Yohei
    Dohi, Tomoharu
    Okada, Katsuki
    Mizuno, Hiroya
    Nakatani, Daisaku
    Yamada, Takahisa
    Yasumura, Yoshio
    Sakata, Yasushi
    ESC HEART FAILURE, 2022, 9 (03): : 1801 - 1811
  • [25] Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
    Fernandes, Amanda D. F.
    Fernandes, Gilson C.
    Ternes, Caique M. P.
    Cardoso, Rhanderson
    Chaparro, Sandra V.
    Goldberger, Jeffrey J.
    HEART RHYTHM O2, 2021, 2 (06): : 724 - 732
  • [26] Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction
    Mujib, Marjan
    Patel, Kanan
    Fonarow, Gregg C.
    Kitzman, Dalane W.
    Zhang, Yan
    Aban, Inmaculada B.
    Ekundayo, O. James
    Love, Thomas E.
    Kilgore, Meredith L.
    Allman, Richard M.
    Gheorghiade, Mihai
    Ahmed, Ali
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (05): : 401 - 410
  • [27] Discontinuation of angiotensin-converting enzyme inhibitors or beta-blockers and the impact on heart failure hospitalization rates
    Knafl, George J.
    Moser, Debra K.
    Wu, Jia-Rong
    Riegel, Barbara
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2019, 18 (08) : 667 - 678
  • [28] Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
    Chitnis, Abhishek S.
    Aparasu, Rajender R.
    Chen, Hua
    Kunik, Mark E.
    Schulz, Paul E.
    Johnson, Michael L.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 395 - 404
  • [29] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
    Chitnis, A. S.
    Johnson, M. L.
    Aparasu, R. R.
    Chen, H.
    Kunik, M. E.
    Schulz, P. E.
    VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [30] SACUBITRIL-VALSARTAN VERSUS ANGIOTENSIN CONVERTING ENZYME INHIBITORS OR ANGIOTENSIN RECEPTOR BLOCKERS IN SYSTOLIC HEART FAILURE: COMPARATIVE OUTCOMES IN CLINICAL PRACTICE
    Tan, Nicholas
    Sangaralingham, Lindsey
    Sangaralingham, Jeson
    Yao, Xiaoxi
    Shah, Nilay
    Dunlay, Shannon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 776 - 776
12345